|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zheng M: Classification and pathology of
lung cancer. Surg Oncol Clin N Am. 25:447–468. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Xu J, Yang H, Jin B, Lou Y, Zhang Y, Zhang
X, Zhong H, Wang H, Wu D and Han B: EGFR tyrosine kinase inhibitors
versus chemotherapy as first-line therapy for non-small cell lung
cancer patients with the L858R point mutation. Sci Repo.
6:382702016. View Article : Google Scholar
|
|
4
|
Burotto M, Manasanch EE, Wilkerson J and
Fojo T: Gefitinib and erlotinib in metastatic non-small cell lung
cancer: A meta-analysis of toxicity and efficacy of randomized
clinical trials. Oncologist. 20:400–410. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rui Y, Peng WJ, Wang M, Wang Q, Liu ZL,
Chen YQ and Huang LN: HIST1H3D: A promising therapeutic target for
lung cancer. Int J Oncol. 50:815–822. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jenuwein T and Allis CD: Translating the
histone code. Science. 293:1074–1080. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rheinbay E, Louis DN, Bernstein BE and
Suvà ML: A tell-tail sign of chromatin: Histone mutations drive
pediatric glioblastoma. Cancer Cell. 21:329–331. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Turner BM: Cellular memory and the histone
code. Cell. 111:285–291. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Iwaya T, Fukagawa T, Suzuki Y, Takahashi
Y, Sawada G, Ishibashi M, Kurashige J, Sudo T, Tanaka F, Shibata K,
et al: Contrasting expression patterns of histone mRNA and microRNA
760 in patients with gastric cancer. Clin Cancer Res. 19:6438–6449.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Austin TO, Matamoros AJ, Friedman JM,
Friedman AJ, Nacharaju P, Yu W, Sharp DJ and Baas PW: Nanoparticle
delivery of fidgetin siRNA as a Microtubule-based therapy to
augment nerve regeneration. Sci Rep. 7:96752017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Park SJ, Kim SJ, Rhee Y, Byun JH, Kim SH,
Kim MH, Lee EJ and Lim SK: Fidgetin-like 1 gene inhibited by basic
fibroblast growth factor regulates the proliferation and
differentiation of osteoblasts. J Bone Miner Res. 22:889–896. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Schraenen A, de Faudeur G, Thorrez L,
Lemaire K, Van Wichelen G, Granvik M, Van Lommel L, In't Veld P and
Schuit F: mRNA expression analysis of cell cycle genes in islets of
pregnant mice. Diabetologia. 53:2579–2588. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hanson PI and Whiteheart SW: AAA+
proteins: Have engine, will work. Nat Rev Mol Cell Biol. 6:519–529.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhao X, Jin M, Wang M, Sun L, Hong X, Cao
Y and Wang C: Fidgetin-like 1 is a ciliogenesis-inhibitory
centrosome protein. Cell Cycle. 15:2367–2375. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Snider J and Houry WA: AAA+ proteins:
Diversity in function, similarity in structure. Biochem Soc Trans.
36:72–77. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Martin J and Lupas A: AAA-ATPases.
Encyclopedia of Biological Chemistry. 2nd edition. Academic Press;
pp. 1–6. 2013
|
|
17
|
Bar-Nun S and Glickman MH: Proteasomal
AAA-ATPases: Structure and function. Biochim Biophys Acta.
1823:67–82. 2012. View Article : Google Scholar
|
|
18
|
Yuan J and Chen J: FIGNL1-containing
protein complex is required for efficient homologous recombination
repair. Proc Natl Acad Sci USA. 110:10640–10645. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hu Z, Feng J, Bo W, Wu R, Dong Z, Liu Y,
Qiang L and Liu M: Fidgetin regulates cultured astrocyte migration
by severing tyrosinated microtubules at the leading edge. Mol Biol
Cell. 28:545–553. 2017. View Article : Google Scholar :
|
|
20
|
Tao J, Feng C and Rolls MM: The
microtubule-severing protein fidgetin acts after dendrite injury to
promote their degeneration. J Cell Sci. 129:3274–3281. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Leo L, Yu W, D'Rozario M, Waddell EA,
Marenda DR, Baird MA, Davidson MW, Zhou B, Wu B, Baker L, et al:
Vertebrate fidgetin restrains axonal growth by severing labile
domains of microtubules. Cell Rep. 12:1723–1730. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
L'Hote D, Vatin M, Auer J, Castille J,
Passet B, Montagutelli X, Serres C and Vaiman D: Fidgetin-like1 is
a strong candidate for a dynamic impairment of male meiosis leading
to reduced testis weight in mice. PLoS One. 6:e275822011.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Truslove MG: The anatomy and development
of the fidget mouse. J Genet. 54:641956. View Article : Google Scholar
|
|
24
|
Ma J, Li J, Yao X, Lin S, Gu Y, Xu J, Deng
Z, Ma W and Zhang H: FIGNL1 is overexpressed in small cell lung
cancer patients and enhances NCI-H446 cell resistance to cisplatin
and etoposide. Oncol Rep. 37:1935–1942. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Detterbeck FC, Boffa DJ, Kim AW and Tanoue
LT: The edition lung cancer stage classification. Chest.
151:193–203. 2016. View Article : Google Scholar
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time Quantitative PCR and
the 2(-Delta Delta C(T)) method. Method. 25:402–408. 2002.
View Article : Google Scholar
|
|
27
|
Ashburner M, Ball CA, Blake JA, Botstein
D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT,
et al: Gene ontology: Tool for the unification of biology. The Gene
Ontology Consortium Nat Genet. 25:25–29. 2000.
|
|
28
|
The Gene Ontology Consortium: The Gene
Ontology Resource: 20 years and still GOing strong. Nucleic Acids
Res. 47:D330–D338. 2019. View Article : Google Scholar :
|
|
29
|
Wang D, Chu M, Wang F, Zhou A, Ruan M and
Chen Y: A Genetic variant in FIGN gene reduces the risk of
congenital heart disease in Han Chinese populations. Pediatr
Cardiol. 38:1169–1174. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lupas AN and Martin J: AAA proteins. Curr
Opin Struct Biol. 12:746–753. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Fontanini G, Macchiarini P, Pepe S,
Ruggiero A, Hardin M, Bigini D, Vignati S, Pingitore R and
Angeletti CA: The expression of proliferating cell nuclear antigen
in paraffin sections of peripheral, node-negative non-small cell
lung cancer. Cancer. 70:1520–1527. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Jackson P, Ridgway P, Rayner J, Noble J
and Braithwaite A: Transcriptional regulation of the PCNA promoter
by p53. Biochem Biophys Res Commun. 203:133–140. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chiang CP, Lang MJ, Liu BY, Wang JT, Leu
JS, Hahn LJ and Kuo MY: Expression of proliferating cell nuclear
antigen (PCNA) in oral submucous fibrosis, oral epithelial
hyperkeratosis and oral epithelial dysplasia in Taiwan. Oral Oncol.
36:353–359. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Srinivasan M and Jewell SD: Quantitative
estimation of PCNA, c-myc, EGFR and TGF-alpha in oral submucous
fibrosis-an immunohistochemical study. Oral Oncol. 37:461–467.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Fan J, Zhou X, Huang J, Wang X and Che G:
Prognostic roles of PCNA expressions in non-small cell lung cancer:
A meta-analysis. Int J Clin Exp Med. 9:5655–5665. 2016.
|
|
36
|
Craig KL and Tyers M: The F-box: A new
motif for ubiquitin dependent proteolysis in cell cycle regulation
and signal transduction. Prog Biophys Mol Biol. 72:299–328. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Bai C, Sen P, Hofmann K, Ma L, Goebl M,
Harper JW and Elledge SJ: SKP1 connects cell cycle regulators to
the ubiquitin proteolysis machinery through a novel motif, the
F-box. Cell. 86:263–274. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Sutterlüty H, Chatelain E, Marti A,
Wirbelauer C, Senften M, Müller U and Krek W: p45SKP2 promotes
p27Kip1 degradation and induces S phase in quiescent cells. Nat
Cell Biol. 1:207–214. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhang H, Kobayashi R, Galaktionov K and
Beach D: p19Skp1 and p45Skp2 are essential elements of the cyclin
A-CDK2 S phase kinase. Cell. 82:915–925. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wu J, Zhang X, Zhang L, Wu CY, Rezaeian
AH, Chan CH, Li JM, Wang J, Gao Y, Han F, et al: Skp2 E3 ligase
integrates ATM activation and homologous recombination repair by
ubiquitinating NBS1. Mol Cell. 46:351–361. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yokoi S, Yasui K, Iizasa T, Takahashi T,
Fujisawa T and Inazawa J: Down-regulation of SKP2 induces apoptosis
in lung-cancer cells. Cancer Sci. 94:344–349. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Han J, Lian M, Fang J, Liu H, Wang R, Zhai
J, Fan Yang Y, Fen L, Shi Q, Zhi Ma H, et al: Minichromosome
maintenance (MCM) protein 4 overexpression is a potential
prognostic marker for laryngeal squamous cell carcinoma. J BUON.
22:1272–1277. 2017.PubMed/NCBI
|
|
43
|
Yang J, Ramnath N, Moysich KB, Asch HL,
Swede H, Alrawi SJ, Huberman J, Geradts J, Brooks JS and Tan D:
Prognostic significance of MCM2, Ki-67 and gelsolin in non-small
cell lung cancer. BMC Cancer. 6:2032006. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zhang X, Teng Y, Yang F, Wang M, Hong X,
Ye LG, Gao YN and Chen GY: MCM2 is a therapeutic target of
lovastatin in human non-small cell lung carcinomas. Oncol Rep.
33:2599–2605. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Liu K, Kang M, Liao X and Wang R:
Genome-wide investigation of the clinical significance and
prospective molecular mechanism of minichromosome maintenance
protein family genes in patients with Lung Adenocarcinoma. PLoS
One. 14:e02194672019. View Article : Google Scholar : PubMed/NCBI
|
